Importance: The United States is experiencing a crisis of opioid overdose. In response, the US Department of Health and Human Services has defined a goal to reduce overdose mortality by 40% by 2022. Objective: To identify specific combinations of 3 interventions (initiating more people to medications for opioid use disorder [MOUD], increasing 6-month retention with MOUD, and increasing naloxone distribution) associated with at least a 40% reduction in opioid overdose in simulated populations. Design, Setting, and Participants: This decision analytical model used a dynamic population-level state-transition model to project outcomes over a 2-year horizon. Each intervention scenario was compared with the counterfactual of no intervention in simulated urban and rural communities in Massachusetts. Simulation modeling was used to determine the associations of community-level interventions with opioid overdose rates. The 3 examined interventions were initiation of more people to MOUD, increasing individuals' retention with MOUD, and increasing distribution of naloxone. Data were analyzed from July to November 2020. Main Outcomes and Measures: Reduction in overdose mortality, medication treatment capacity needs, and naloxone needs. Results: No single intervention was associated with a 40% reduction in overdose mortality in the simulated communities. Reaching this goal required use of MOUD and naloxone. Achieving a 40% reduction required that 10% to 15% of the estimated OUD population not already receiving MOUD initiate MOUD every month, with 45% to 60%% retention for at least 6 months, and increased naloxone distribution. In all feasible settings and scenarios, attaining a 40% reduction in overdose mortality required that in every month, at least 10% of the population with OUD who were not currently receiving treatment initiate an MOUD. Conclusions and Relevance: In this modeling study, only communities with increased capacity for treating with MOUD and increased MOUD retention experienced a 40% decrease in overdose mortality. These findings could provide a framework for developing community-level interventions to reduce opioid overdose death.
Importance: The United States is experiencing a crisis of opioid overdose. In response, the US Department of Health and Human Services has defined a goal to reduce overdose mortality by 40% by 2022. Objective: To identify specific combinations of 3 interventions (initiating more people to medications for opioid use disorder [MOUD], increasing 6-month retention with MOUD, and increasing naloxone distribution) associated with at least a 40% reduction in opioid overdose in simulated populations. Design, Setting, and Participants: This decision analytical model used a dynamic population-level state-transition model to project outcomes over a 2-year horizon. Each intervention scenario was compared with the counterfactual of no intervention in simulated urban and rural communities in Massachusetts. Simulation modeling was used to determine the associations of community-level interventions with opioid overdose rates. The 3 examined interventions were initiation of more people to MOUD, increasing individuals' retention with MOUD, and increasing distribution of naloxone. Data were analyzed from July to November 2020. Main Outcomes and Measures: Reduction in overdose mortality, medication treatment capacity needs, and naloxone needs. Results: No single intervention was associated with a 40% reduction in overdose mortality in the simulated communities. Reaching this goal required use of MOUD and naloxone. Achieving a 40% reduction required that 10% to 15% of the estimated OUD population not already receiving MOUD initiate MOUD every month, with 45% to 60%% retention for at least 6 months, and increased naloxone distribution. In all feasible settings and scenarios, attaining a 40% reduction in overdose mortality required that in every month, at least 10% of the population with OUD who were not currently receiving treatment initiate an MOUD. Conclusions and Relevance: In this modeling study, only communities with increased capacity for treating with MOUD and increased MOUD retention experienced a 40% decrease in overdose mortality. These findings could provide a framework for developing community-level interventions to reduce opioid overdose death.
Authors: Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi Journal: JAMA Netw Open Date: 2020-02-05
Authors: Michael A Irvine; Jane A Buxton; Michael Otterstatter; Robert Balshaw; Reka Gustafson; Mark Tyndall; Perry Kendall; Thomas Kerr; Mark Gilbert; Daniel Coombs Journal: Lancet Public Health Date: 2018-04-18
Authors: Joshua D Lee; Edward V Nunes; Patricia Novo; Ken Bachrach; Genie L Bailey; Snehal Bhatt; Sarah Farkas; Marc Fishman; Phoebe Gauthier; Candace C Hodgkins; Jacquie King; Robert Lindblad; David Liu; Abigail G Matthews; Jeanine May; K Michelle Peavy; Stephen Ross; Dagmar Salazar; Paul Schkolnik; Dikla Shmueli-Blumberg; Don Stablein; Geetha Subramaniam; John Rotrosen Journal: Lancet Date: 2017-11-14 Impact factor: 79.321
Authors: Elenore Patterson Bhatraju; Ellie Grossman; Babak Tofighi; Jennifer McNeely; Danae DiRocco; Mara Flannery; Ann Garment; Keith Goldfeld; Marc N Gourevitch; Joshua D Lee Journal: Addict Sci Clin Pract Date: 2017-02-28
Authors: William C Goedel; Aaron Shapiro; Magdalena Cerdá; Jennifer W Tsai; Scott E Hadland; Brandon D L Marshall Journal: JAMA Netw Open Date: 2020-04-01
Authors: Caroline A King; Ryan Cook; Haven Wheelock; P Todd Korthuis; Judith M Leahy; Amelia Goff; Cynthia D Morris; Honora Englander Journal: Int J Drug Policy Date: 2021-11-24
Authors: Xiao Zang; Alexandria Macmadu; Maxwell S Krieger; Czarina N Behrends; Traci C Green; Jake R Morgan; Sean M Murphy; Shayla Nolen; Alexander Y Walley; Bruce R Schackman; Brandon Dl Marshall Journal: Int J Drug Policy Date: 2021-09-03
Authors: Alexandra Savinkina; Rajapaksha W M A Madushani; Golnaz Eftekhari Yazdi; Jianing Wang; Joshua A Barocas; Jake R Morgan; Sabrina A Assoumou; Alexander Y Walley; Benjamin P Linas; Sean M Murphy Journal: Addiction Date: 2022-04-12 Impact factor: 7.256
Authors: Tse Yang Lim; Erin J Stringfellow; Celia A Stafford; Catherine DiGennaro; Jack B Homer; Wayne Wakeland; Sara L Eggers; Reza Kazemi; Lukas Glos; Emily G Ewing; Calvin B Bannister; Keith Humphreys; Douglas C Throckmorton; Mohammad S Jalali Journal: Proc Natl Acad Sci U S A Date: 2022-05-31 Impact factor: 12.779
Authors: Jake R Morgan; Alexander Y Walley; Sean M Murphy; Avik Chatterjee; Scott E Hadland; Joshua Barocas; Benjamin P Linas; Sabrina A Assoumou Journal: Drug Alcohol Depend Date: 2021-05-21 Impact factor: 4.852
Authors: Erin J Stringfellow; Tse Yang Lim; Keith Humphreys; Catherine DiGennaro; Celia Stafford; Elizabeth Beaulieu; Jack Homer; Wayne Wakeland; Benjamin Bearnot; R Kathryn McHugh; John Kelly; Lukas Glos; Sara L Eggers; Reza Kazemi; Mohammad S Jalali Journal: Sci Adv Date: 2022-06-24 Impact factor: 14.957